Endocrine Peptide Test Market Size, Share, Growth, Forecast 2030
Endocrine Peptide Test Market By Test Type (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Estradiol, Gonadotropin, Thyroid-stimulating Hormone, and Others), By End-User (Clinics, Healthcare Centers, Hospitals, and Commercial Laboratories), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028
Category: Healthcare Report Format : PDF
Pages: 260 Report Code: ZMR-7007
Published Date: Jul-2022 Status : Published
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 7.04 Billion | USD 11 Billion | 8% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Endocrine Peptide Test Market, (2022 - 2028) (USD Billion)
- 2.2 Global Endocrine Peptide Test Market : snapshot
- Chapter 3. Global Endocrine Peptide Test Market - Industry Analysis
- 3.1 Endocrine Peptide Test Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Prevalence of diabetes amongst the masses induces market growth
- 3.3 Market Restraints
- 3.3.1. High costs associated with endocrine peptide testing methods hamper the market growth
- 3.4 Market Opportunities
- 3.4.1. Advancement in the endocrine testing method to bring precision is a great opportunity for market expansion
- 3.5 Market Challenges
- 3.5.1. High costs associated with these testing methods pose a challenge to the market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Test-Type
- 3.7.2 Market attractiveness analysis By End-Users
- Chapter 4. Global Endocrine Peptide Test Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Endocrine Peptide Test Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Endocrine Peptide Test Market - Test-Type Analysis
- 5.1 Global Endocrine Peptide Test Market overview: By Test-Type
- 5.1.1 Global Endocrine Peptide Test Market share, By Test-Type, 2021 and 2028
- 5.2 Dehydroepiandrosterone Sulphate
- 5.2.1 Global Endocrine Peptide Test Market by Dehydroepiandrosterone Sulphate, 2022 - 2028 (USD Billion)
- 5.3 Progesterone
- 5.3.1 Global Endocrine Peptide Test Market by Progesterone, 2022 - 2028 (USD Billion)
- 5.4 Luteinizing hormone
- 5.4.1 Global Endocrine Peptide Test Market by Luteinizing hormone, 2022 - 2028 (USD Billion)
- 5.5 Thyroid Prolactin
- 5.5.1 Global Endocrine Peptide Test Market by Thyroid Prolactin, 2022 - 2028 (USD Billion)
- 5.6 Oestradiol
- 5.6.1 Global Endocrine Peptide Test Market by Oestradiol, 2022 - 2028 (USD Billion)
- 5.7 Human Chorionic Gonadotropin
- 5.7.1 Global Endocrine Peptide Test Market by Human Chorionic Gonadotropin, 2022 - 2028 (USD Billion)
- 5.8 Thyroid-stimulating Hormone
- 5.8.1 Global Endocrine Peptide Test Market by Thyroid-stimulating Hormone, 2022 - 2028 (USD Billion)
- 5.9 Others
- 5.9.1 Global Endocrine Peptide Test Market by Others, 2022 - 2028 (USD Billion)
- 5.1 Global Endocrine Peptide Test Market overview: By Test-Type
- Chapter 6. Global Endocrine Peptide Test Market - End-Users Analysis
- 6.1 Global Endocrine Peptide Test Market overview: By End-Users
- 6.1.1 Global Endocrine Peptide Test Market share, By End-Users, 2021 and 2028
- 6.2 Clinics
- 6.2.1 Global Endocrine Peptide Test Market by Clinics, 2022 - 2028 (USD Billion)
- 6.3 Healthcare Centers
- 6.3.1 Global Endocrine Peptide Test Market by Healthcare Centers, 2022 - 2028 (USD Billion)
- 6.4 Hospitals
- 6.4.1 Global Endocrine Peptide Test Market by Hospitals, 2022 - 2028 (USD Billion)
- 6.5 Commercial Laboratories
- 6.5.1 Global Endocrine Peptide Test Market by Commercial Laboratories, 2022 - 2028 (USD Billion)
- 6.1 Global Endocrine Peptide Test Market overview: By End-Users
- Chapter 7. Endocrine Peptide Test Market - Regional Analysis
- 7.1 Global Endocrine Peptide Test Market Regional Overview
- 7.2 Global Endocrine Peptide Test Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
- 7.3.1 North America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.3.1.1 North America Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
- 7.3.1 North America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4 North America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
- 7.4.1 North America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
- 7.5 North America Endocrine Peptide Test Market, by End-Users, 2022 - 2028
- 7.5.1 North America Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4.2.1 Europe Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
- 7.4.2 Europe Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4 Europe Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
- 7.4.1 Europe Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
- 7.5 Europe Endocrine Peptide Test Market, by End-Users, 2022 - 2028
- 7.5.1 Europe Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.5.3.1 Asia Pacific Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
- 7.5.3 Asia Pacific Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
- 7.4.1 Asia Pacific Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Endocrine Peptide Test Market, by End-Users, 2022 - 2028
- 7.5.1 Asia Pacific Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.6.4.1 Latin America Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
- 7.6.4 Latin America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4 Latin America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
- 7.4.1 Latin America Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
- 7.5 Latin America Endocrine Peptide Test Market, by End-Users, 2022 - 2028
- 7.5.1 Latin America Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Endocrine Peptide Test Market, by Country, 2022 - 2028 (USD Billion)
- 7.7.5 The Middle-East and Africa Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Endocrine Peptide Test Market, by Test-Type, 2022 - 2028
- 7.4.1 The Middle-East and Africa Endocrine Peptide Test Market, by Test-Type, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Endocrine Peptide Test Market, by End-Users, 2022 - 2028
- 7.5.1 The Middle-East and Africa Endocrine Peptide Test Market, by End-Users, 2022 - 2028 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Agilent Technologies
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Abbott Laboratories
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Biomedical Diagnostics
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Bio-Rad Laboratories
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Hoffman- La Roche Ltd
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 ImmunoDX
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Laboratory Corporation
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Nano Entek
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Siemens AG
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Thermo Fischer Scientific Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 and BioMerieux.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.1 Agilent Technologies
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Endocrine Peptide Test Market attractiveness, By Test-Type
- 6. Global Endocrine Peptide Test Market attractiveness, By End-Users
- 7. Global Endocrine Peptide Test Market share by Test-Type, 2022 and 2028 (USD Billion)
- 8. Global Endocrine Peptide Test Market by Dehydroepiandrosterone Sulphate, 2022 - 2028 (USD Billion)
- 9. Global Endocrine Peptide Test Market by Progesterone, 2022 - 2028 (USD Billion)
- 10. Global Endocrine Peptide Test Market by Luteinizing hormone, 2022 - 2028 (USD Billion)
- 11. Global Endocrine Peptide Test Market by Thyroid Prolactin, 2022 - 2028 (USD Billion)
- 12. Global Endocrine Peptide Test Market by Oestradiol, 2022 - 2028 (USD Billion)
- 13. Global Endocrine Peptide Test Market by Human Chorionic Gonadotropin, 2022 - 2028 (USD Billion)
- 14. Global Endocrine Peptide Test Market by Thyroid-stimulating Hormone, 2022 - 2028 (USD Billion)
- 15. Global Endocrine Peptide Test Market by Others, 2022 - 2028 (USD Billion)
- 16. Global Endocrine Peptide Test Market share by End-Users, 2022 and 2028 (USD Billion)
- 17. Global Endocrine Peptide Test Market by Clinics, 2022 - 2028 (USD Billion)
- 18. Global Endocrine Peptide Test Market by Healthcare Centers, 2022 - 2028 (USD Billion)
- 19. Global Endocrine Peptide Test Market by Hospitals, 2022 - 2028 (USD Billion)
- 20. Global Endocrine Peptide Test Market by Commercial Laboratories, 2022 - 2028 (USD Billion)
- 21. Global Endocrine Peptide Test Market share, by Region, 2022 and 2028
- 22. North America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 23. Europe Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 25. Latin America Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
- 26. The Middle-East and Africa Endocrine Peptide Test Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Endocrine Peptide Test Market: Snapshot
- 2. Drivers of the Endocrine Peptide Test Market: impact analysis
- 3. North America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 4. North America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 5. U.S. Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 6. U.S. Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 7. Canada Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 8. Canada Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 9. Europe Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 10. Europe Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 11. Germany Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 12. Germany Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 13. France Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 14. France Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 15. U.K. Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 16. U.K. Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 17. Italy Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 18. Italy Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 19. Spain Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 20. Spain Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 21. Rest of Europe Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 22. Rest of Europe Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 25. China Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 26. China Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 27. Japan Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 28. Japan Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 29. India Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 30. India Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 31. South Korea Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 32. South Korea Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 33. South-East Asia Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 34. South-East Asia Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 35. Rest of Asia Pacific Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 36. Rest of Asia Pacific Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 37. Latin America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 38. Latin America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 39. Brazil Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 40. Brazil Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 41. Mexico Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 42. Mexico Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 43. Rest of Latin America Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 44. Rest of Latin America Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 45. The Middle-East and Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 46. The Middle-East and Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 47. GCC Countries Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 48. GCC Countries Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 49. South Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 50. South Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
- 51. Rest of Middle-East Africa Endocrine Peptide Test Market revenue, By Test-Type, 2022 - 2028 (USD Billion)
- 52. Rest of Middle-East Africa Endocrine Peptide Test Market revenue, By End-Users, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
One of the main factors that propel the demand for endocrine peptide testing is the extreme prevalence of diabetic patients all over the world. Thyroid disorders and infertility have also been very predominant in recent times which triggers excessive leverage of endocrine peptide tests.
The global Endocrine Peptide Test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period. In this report, we will cover the full overview, growth drivers, opportunities, and obstacles of the bubble tea market from 2022 -to 2028
North America leads as the major contributor to the endocrine peptide tests market due to the excessive presence of endocrine disorders in that region. There is also an increase in the overall rate of the geriatric population which leads to an increase in the leverage of endocrine tests.
The key market players are Agilent Technologies, Abbott Laboratories, Biomedical Diagnostics, Bio-Rad Laboratories, Hoffman- La Roche Ltd, ImmunoDX, Laboratory Corporation, Nano Entek, Siemens AG, Thermo Fischer Scientific Inc., and BioMerieux.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed